A 14-step desensitization protocol for sebelipase alfa hypersensitivity in a patient with Wolman disease and secondary hemophagocytic lymphohistiocytosis
Pediatr Allergy Immunol
.
2024 Apr;35(4):e14121.
doi: 10.1111/pai.14121.
Authors
Minh H N Nguyen
1
,
Rachel Bruening
2
,
Trent Abel
2
,
Shannon Lyons
2
,
Brenna Denhardt
3
,
Jenna Moore
3
,
Panida Sriaroon
1
,
Monica Hajirawala
1
,
Alexander Y Kim
4
Affiliations
1
Division of Allergy and Immunology, Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.
2
Department of Pharmacy, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
3
Nutritional Services, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
4
Division of Genetics, Department of Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
PMID:
38572778
DOI:
10.1111/pai.14121
No abstract available
MeSH terms
Humans
Hypersensitivity* / complications
Lymphohistiocytosis, Hemophagocytic* / therapy
Sterol Esterase
Wolman Disease* / complications
Substances
Sebelipase alfa
Sterol Esterase